Evidence map›Paper›PMID 33033381›Full record

ArticleScientific reports2020

The first versatile human iPSC-based model of ectopic virus induction allows new insights in RNA-virus disease.

Stefan Peischard, Huyen Tran Ho, Ilaria Piccini, Nathalie Strutz-Seebohm, Albrecht Röpke, Ivan Liashkovich, Hiteshika Gosain, Bettina Rieger, Karin Klingel, Britta Eggers and 7 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Stefan PeischardInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Huyen Tran HoInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Ilaria PicciniInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Nathalie Strutz-SeebohmInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany.
Albrecht RöpkeInstitute of Human Genetics, University Hospital Münster, 48149, Münster, Germany.
Ivan LiashkovichInstitute of Physiology II, Faculty of Medicine, University of Münster, 48149, Münster, Germany.
Hiteshika GosainInstitute of Molecular Cell Biology, Department of Biology, University of Münster, 48149, Münster, Germany.
Bettina RiegerInstitute of Molecular Cell Biology, Department of Biology, University of Münster, 48149, Münster, Germany.
Karin KlingelCardiopathology, Institute for Pathology and Neuropathology, University Hospital Tübingen, Liebermeisterstrasse 8, 72076, Tübingen, Germany.
Britta EggersFaculty of Medicine, Medizinisches Proteom-Center, Ruhr-University Bochum, 44801, Bochum, Germany.
Katrin MarcusFaculty of Medicine, Medizinisches Proteom-Center, Ruhr-University Bochum, 44801, Bochum, Germany.
Wolfgang A LinkeInstitute of Physiology II, Faculty of Medicine, University of Münster, 48149, Münster, Germany.
Frank Ulrich MüllerInstitute of Pharmacology and Toxicology, University of Münster, 48149, Münster, Germany.
Stephan LudwigInterdisciplinary Centre for Clinical Research (IZKF), Faculty of Medicine, University of Münster, 48149, Münster, Germany.
Boris GreberHuman Stem Cell Pluripotency Laboratory, Max Planck Institute for Molecular Biomedicine, 48149, Münster, Germany.
Karin BuschInstitute of Molecular Cell Biology, Department of Biology, University of Münster, 48149, Münster, Germany.
Guiscard SeebohmInstitute for Genetics of Heart Diseases (IfGH), Department of Cardiovascular Medicine, University Hospital Münster, 48149, Münster, Germany. guiscard.seebohm@ukmuenster.de.
University of Münster · DEUniversity Hospital Münster · DERuhr University Bochum · DEChemical Genomics Centre · DEMax Planck Institute for Molecular Biomedicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A detailed description of pathophysiological effects that viruses exert on their host is still challenging. For the first time, we report a highly controllable viral expression model based on an iPS-cell line from a healthy human donor. The established viral model system enables a dose-dependent and highly localized RNA-virus expression in a fully controllable environment, giving rise for new applications for the scientific community.

Indexed as

Cell LineDoxycyclineHumansInduced Pluripotent Stem CellsModels, BiologicalMyocytes, CardiacRNA VirusesRNA Virus InfectionsVirus ActivationDoxycycline

Identifiers

PMID33033381
PMCPMC7546621
OpenAlexW3092608409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.